Cargando…

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

Inflammatory bowel disease (IBD) is characterized by chronic and relapsing inflammation of gastrointestinal tract, with steadily increased incidence and prevalence worldwide. Although the precise pathogenesis remains unclear, gut microbiota, bile acids (BAs), and aberrant immune response play essent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lingfeng, Liu, Tianyu, Gu, Yu, Wang, Xinyu, Xie, Runxiang, Sun, Yue, Wang, Bangmao, Cao, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539765/ https://www.ncbi.nlm.nih.gov/pubmed/36211363 http://dx.doi.org/10.3389/fimmu.2022.974305

Ejemplares similares

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
por: Yang, Min, et al.
Publicado: (2021)

Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood
por: Xie, Runxiang, et al.
Publicado: (2018)

Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis
por: Wang, Sinan, et al.
Publicado: (2019)

Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults
por: Sun, Yue, et al.
Publicado: (2019)

Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
por: Dong, Yue, et al.
Publicado: (2023)

Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges
por: Yan, Jing, et al.
Publicado: (2022)

Gut microbiota in COVID-19: new insights from inside
por: Zhou, Bingqian, et al.
Publicado: (2023)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota
por: Sun, Siyuan, et al.
Publicado: (2021)

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges
por: Zhang, Wanru, et al.
Publicado: (2021)

The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
por: Gu, Yu, et al.
Publicado: (2019)

Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices
por: Tang, Qiang, et al.
Publicado: (2020)

Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer
por: Liu, Li, et al.
Publicado: (2021)

Gut Microbiota in Celiac Disease: Is There Any Role for Probiotics?
por: Pecora, Francesco, et al.
Publicado: (2020)

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
por: Li, Mengfan, et al.
Publicado: (2022)

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
por: Su, Xiaomin, et al.
Publicado: (2023)

The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
por: Thomas, John P., et al.
Publicado: (2022)

Irritable Bowel Syndrome, Gut Microbiota and Probiotics
por: Lee, Beom Jae, et al.
Publicado: (2011)

Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure
por: Nardone, Olga Maria, et al.
Publicado: (2021)

Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood
por: Jin, Ge, et al.
Publicado: (2021)

The “Gum–Gut” Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances
por: Byrd, Kevin M., et al.
Publicado: (2021)

Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)

The gut-lung axis in influenza A: the role of gut microbiota in immune balance
por: Ou, Guosen, et al.
Publicado: (2023)

Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood
por: Sun, Yue, et al.
Publicado: (2021)

Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease
por: Du, Gang, et al.
Publicado: (2021)

Role of Incretin Axis in Inflammatory Bowel Disease
por: Duan, Lihua, et al.
Publicado: (2017)

Implications of Probiotics on the Maternal-Neonatal Interface: Gut Microbiota, Immunomodulation, and Autoimmunity
por: Swartwout, Brianna, et al.
Publicado: (2018)

Microbiota Modulation of the Gut-Lung Axis in COVID-19
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
por: Mörkl, Sabrina, et al.
Publicado: (2020)

Microbiota–Gut–Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics
por: Ding, Manqiu, et al.
Publicado: (2021)

Dietary feeding of freeze-dried whole cranberry inhibits intestinal tumor development in Apc(min/+) mice
por: Jin, Duochen, et al.
Publicado: (2017)

The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration
por: Zheng, Zhipeng, et al.
Publicado: (2021)

Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review
por: Fang, Zhifeng, et al.
Publicado: (2021)

Targeting Desulfovibrio vulgaris flagellin-induced NAIP/NLRC4 inflammasome activation in macrophages attenuates ulcerative colitis
por: An, Yaping, et al.
Publicado: (2023)

NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host–Gut Microbiota Interactions during Inflammatory Bowel Disease
por: Leber, Andrew, et al.
Publicado: (2018)

Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
por: Banfi, Davide, et al.
Publicado: (2021)

Parasite-Probiotic Interactions in the Gut: Bacillus sp. and Enterococcus faecium Regulate Type-2 Inflammatory Responses and Modify the Gut Microbiota of Pigs During Helminth Infection
por: Myhill, Laura J., et al.
Publicado: (2022)

The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases
por: Alagón Fernández del Campo, Pablo, et al.
Publicado: (2019)

COF-based artificial probiotic for modulation of gut microbiota and immune microenvironment in inflammatory bowel disease
por: Deng, Qingqing, et al.
Publicado: (2022)

Gut Microbiota in NSAID Enteropathy: New Insights From Inside
por: Wang, Xianglu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16e8r5ga4eaqs6vm1grodtqb4g